SKINVISIBLE, INC.
SKVI · OTCMCIK 1085277fmd_1Z5CTFB587ZKSJE58QJNFJ1RVWManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2010 to Jun 30, 2026, 65 periods
| Line item | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenues | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 |
| Cost of revenue | 0 | 0 | 0 | 0 | – | 0 | 0 | – | – | – |
| Gross profit | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 |
| Selling, general and administrative | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 1 | 0 |
| Total operating expenses | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 1 | 1 |
| Operating income | (1) | (0) | (1) | (1) | (0) | 0 | (0) | (0) | (1) | (0) |
| Interest expense | 1 | 2 | 1 | 1 | 1 | 1 | 1 | 2 | 1 | 1 |
| Income before taxes | – | – | – | (2) | (1) | – | – | – | – | – |
| Net income | (2) | (2) | 0 | (2) | (1) | (1) | (1) | (2) | (1) | (1) |